Seth Klarman’s portfolio: Baupost Group 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001061768Latest: Q2 2026

Q4 2014 filing in brief

In its Q4 2014 13F, filed February 13, 2015, Baupost Group reported $5.1B across 27 US positions. The largest: LNG (19.1%), VSAT (14.3%), MU (13.6%), EBAY (10.3%), AR (6.3%). In the quarter it opened 4 positions, sold out of 4, added to 8 and trimmed 5; positions opened and sold out came to 9.9% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Feb 13, 2015

  • 4 New
  • 8 Added
  • 5 Trimmed
  • 4 Exited

27 positions at December 31, 2014. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1LNGCHENIERE ENERGY INC$972M13.8M19.09%+23.3%Added
2VSATVIASAT INC$727M11.5M14.28%0.0%Held
3MUMICRON TECHNOLOGY INC$690M19.7M13.55%−61.9%Trimmed
4EBAYEBAY INC$523M9.3M10.27%+52.8%Added
5ARANTERO RES CORP$318M7.8M6.26%+184.4%Added
6—THERAVANCE INC$280M19.8M5.51%0.0%Held
7—KERYX BIOPHARMACEUTICALS INC$259M18.3M5.09%0.0%Held
8PBFPBF ENERGY INC$231M8.7M4.53%+21.2%Added
9VRTVEURVERITIV CORP$120M2.3M2.36%−2.1%Trimmed
10—FORWARD PHARMA A/S$112M5.4M2.20%—New
11—THERAVANCE BIOPHARMA INC$90M6.1M1.78%0.0%Held
12OCN2EUROCWEN FINL CORP$90M6.0M1.77%−14.8%Trimmed
13—CITIGROUP INC$89M102.7M1.75%−16.2%Trimmed
14—SUNEDISON SEMICONDUCTOR LTD$77M4.1M1.51%0.0%Held
15—CHIPMOS TECH BERMUDA LTD$77M3.3M1.50%0.0%Held
16—BELLATRIX EXPLORATION LTD$66M18.1M1.29%—New
17NGNOVAGOLD RES INC$64M21.7M1.26%0.0%Held
18PRTKEURPARATEK PHARMACEUTICALS INC$62M1.7M1.22%—New
19—KOSMOS ENERGY LTD$61M7.2M1.19%+52.5%Added
20ATRAGBXATARA BIOTHERAPEUTICS INC$59M2.5M1.16%—New
21INVA 2.125 01/15/23THERAVANCE INC$31M40.1M0.62%+134.6%Added
22—SYNERON MEDICAL LTD$23M2.4M0.44%−19.3%Trimmed
23KIN1USDKINDRED BIOSCIENCES INC$22M3.0M0.44%0.0%Held
24—AMERICAN INTL GROUP INC$22M889.4K0.43%+12.7%Added
25ALDWUSDALON USA PARTNERS LP$12M954.2K0.24%+189.9%Added
26—ALLIANCE ONE INTL INC$10M6.4M0.20%0.0%Held
27—NOVACOPPER INC$3M6.0M0.06%0.0%Held
4 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
—RF MICRODEVICES INC$113M9.8M
—TRIQUINT SEMICONDUCTOR INC$112M5.9M
BYDBOYD GAMING CORP$10M979.5K
AVEOEURAVEO PHARMACEUTICALS INC$4M3.8M
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.